Back to search results

Observational Study on Stress During Financial Volatility

This is an observational study called the NeuroFinance Human Stress Trial. It aims to understand how financial market changes, economic uncertainty, and digital information affect your body and behavior. You would use wearable devices, like smartwatches, to continuously or intermittently collect data on your heart rate variability (how much your heart rate changes between beats), sleep, and resting heart rate. Researchers will look for changes in these measures over 24 months to see how they relate to financial and informational stress. This study is for adults aged 18 and older who can use a smartphone or internet-connected device and are willing to wear monitoring technologies. There is no investigational drug or invasive procedure involved.

Study design
This is an observational study with a planned enrollment of 2500 participants. It is a decentralized study, meaning you can participate remotely.
What's involved
You would use wearable physiologic monitoring technologies and a compatible smartphone or internet-connected device for remote monitoring over 24 months.
Compensation
Not stated in the trial record.
Follow-up
Your heart rate variability, sleep duration, and resting heart rate will be measured from the beginning of the study through 24 months.

AI-generated from the public study record. Only the study team can confirm whether you're eligible — confirm details with them before making decisions.

NCT07622589

NeuroFinance Human Stress Trial During Financial and Informational Volatility

Enrolling by Invitation
Not specifiedAges 18+Observational
Truway Health, Inc.
~2,500 participants
Updated 2026-08-25 on ClinicalTrials.gov
What's tested:Wearable Physiologic Monitoring Platform

At a glance

Recruiting sites
0 of 1 listed site is recruiting right now
RecruitingSuspended, closed, or not yet open
What they're measuring
Change in Heart Rate Variability (HRV) During Financial Stress Exposure
Measured over Baseline through 24 Months
+3 more outcomes measured

Conditions

Psychological Stress
Anxiety
Emotional Stress
Autonomic Nervous System Dysfunction
Sleep Disturbance
Insomnia
Behavioral Health
Cognitive Fatigue
Occupational Stress
Financial Stress
Burnout Syndrome
Heart Rate Variability
Neurobehavioral Manifestations

Explore related trials

AnxietyAUTONOMIC NERVOUS SYSTEM DYSFUNCTIONBurnout, PsychologicalCognitive fatigueEmotional stressFinancial StressHealth BehaviorInsomniaJob StrainPhysiological stressPsychological stressSleep Disorder

Where it's being run

1 sites across 1 states
New York1

Study leadership

  • Gavin C Solomon, Investigator · PRINCIPAL_INVESTIGATOR · Truway Health, Inc.

Who to contact

This trial hasn't published a contact. View it on ClinicalTrials.gov

Do you actually qualify for this trial?

Add a private profile and we'll compare every criterion below against your situation — and tell you which ones are met, uncertain, or excluding.

Check eligibility for this trial ~2 min · HIPAA-protected · delete anytime
Eligibility criteria

Inclusion

Adults age 18 years and older.
Ability to provide informed consent.
Willingness and ability to comply with study procedures and remote monitoring requirements.
Access to a compatible smartphone, tablet, or internet-connected device for decentralized study participation.
Willingness to utilize wearable physiologic monitoring technologies during the study period.
Participants with varying degrees of financial market exposure, occupational stress exposure, or digital media exposure are eligible.
Healthy volunteers and participants with self-reported stress-related symptoms may be enrolled.
Ability to read and understand English-language consent and study materials.

Exclusion

Individuals unable or unwilling to provide informed consent.
Individuals unable to comply with remote monitoring procedures or wearable device usage requirements.
Active medical or psychiatric instability that, in the opinion of study investigators, may interfere with study participation or data integrity.
Current incarceration or institutionalization limiting voluntary participation.
Participation in another interventional clinical trial that may substantially interfere with physiologic monitoring outcomes.
Any condition that would significantly impair safe study participation as determined by the study investigators.

What this trial measures

  • Change in Heart Rate Variability (HRV) During Financial Stress ExposureBaseline through 24 Months

    Heart rate variability will be measured using wearable electrocardiographic or photoplethysmographic monitoring devices. HRV will be quantified as the root mean square of successive differences (RMSSD) in milliseconds. Higher RMSSD values generally indicate improved autonomic nervous system flexibility and lower physiologic stress burden.

  • Change in Sleep DurationBaseline through 24 Months

    Sleep duration will be measured in hours per night using wearable sleep monitoring devices.

  • Change in Resting Heart RateBaseline through 24 Months

    Resting heart rate will be measured in beats per minute using wearable biosensor devices.

  • Change in Perceived Stress Scale-10 (PSS-10) Total ScoreBaseline through 24 Months

    Perceived stress will be assessed using the validated 10-item Perceived Stress Scale-10 questionnaire. Scores range from 0 to 40, with higher scores indicating greater perceived psychological stress and worse stress-related outcomes.